Centene reaffirms FY2025 guidance: GAAP loss <= $(12.85), adj. EPS >= $2.00

CENTENE CORP

2025-Q3 EPS reported -$11.29 revenue$145,052,000,000

Full-year GAAP diluted loss per share expected not to exceed $(12.85).
Full-year adjusted diluted EPS forecast of at least $2.00.
Management to present at UBS Global Healthcare Conference on Nov 11, 2025, at 10:15 a.m. EST.
Guidance unchanged from prior issuance; no new financial metrics provided.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.